ArticleBMC neurology2010

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study.

Felix Bermejo-Pareja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.